EPIC-NL

European Prospective Investigation Into Cancer and Nutrition in the Netherlands (EPIC-NL)...

Description

EPIC is the European Prospective Investigation Into Cancer and Nutrition. EPIC-NL is the Dutch contribution to EPIC and comprises about 40,000 individuals prospectively followed since the early 90's. Biological samples have been stored in liquid nitr...

General Design

Type
Cohort study
Cohort type
Population cohort
Data collection type
Prospective
Design
Longitudinal
Design description
At baseline, the prevalence of risk factors for chronic diseases was determined using self-administered questionnaires and a physical examination. Participants are followed up over time for changes in exposure and for the occurrence of cancer, diabetes, cardiovascular diseases, and other medical conditions. Subgroups of participants were invited for several follow-up rounds.
Design schematic
Design schematic
Start/End data collection
1993 (ongoing)
Design papers
PID
https://doi.org/10.71739/wfnj-cj15

Population

Countries
Netherlands (the)
Regions
Limburg, Noord-Holland, Utrecht, Gelderland
Number of participants
40010
Population age groups
Adult (18+ years)
Inclusion criteria
Age group inclusion criterion

Organisations

Lead organisations

Contributors

  • dr.  N.C. (Charlotte) Onland-MoretUniversity Medical Center Utrecht

    Principal Investigator

  • prof. dr. ir.  R.C.H. (Roel) VermeulenUniversity Medical Center Utrecht

    Principal Investigator

  • prof. dr. ir.  W.M.M. (Monique) VerschurenNational Institute for Public Health and the Environment

    Principal Investigator

  • EPIC-NL Study teamepicnl@umcutrecht.nl

    Primary contact

Available Data & Samples

Data categories

  • Biological samples
  • Survey data
  • National registries
  • Physiological/Biochemical measurements

Sample categories

  • Blood

Areas of information

  • Socio-demographic and economic characteristics
  • Lifestyle and behaviours
  • Birth, pregnancy and reproductive health history
  • Perception of health, quality of life, development and functional limitations
  • Symptoms and signs
  • Medication and supplements
  • Health and community care services utilization
  • Physical measures and assessments
  • Laboratory measures
  • Cognition, personality and psychological measures and assessments
  • Physical environment

Subpopulations

List of subpopulations for this resource...

No results for current selection

Collection events

List of collection events defined for this resource...

No results for current selection

Networks

Part of networks...

  • Welkom bij Health Data Space Utrecht, het portaal dat de regio Utrecht verbindt door onderzoekers en professionals samen te brengen om kennis en data te delen....

Publications

Access conditions

A data request is judged by the scientific steering committee. The application form can be found in the documents. The EPIC-NL steering committee is not responsible for further legal procedures and researchers need to make a DMP and n-WMO request in ...

Data access conditions
  • health or medical or biomedical research
  • disease specific research
Data use conditions
  • research specific restrictions
  • not for profit, non commercial use only
Data access fee
true
Release type
Other release type
Release description
In principle data will be made available in a secure data analysis environment after signing a data sharing agreement. nWMO testing and the development of a datamanagementplan need to be part of the project and are the responsibility of the researcher.
Prelinked
true
Linkage options
CBS (national bureau of statistics); IKNL-NKR (Cancer registration); DHD (Dutch Hospital Discharge diagnosis); GBA (municipal registry for current address and vital status)

Funding & Acknowledgements

Funding
The EPIC-NL study was funded by ‘Europe against Cancer’ Programme of the European Commission (DG SANCO); the Dutch Ministry of Health, Welfare and Sports (VWS); the Netherlands Organisation for Health Research and Development (ZonMW); and World Cancer Research Fund (WCRF).
Acknowledgements
We thank GBA, Statistics Netherlands, Dutch Cancer Registry and the institute PHARMO for providing data on vital status, cause of death and occurrence of cancer and other chronic diseases.

Documentation